185 related articles for article (PubMed ID: 17101502)
1. Pathogenic monoclonal antibody against desmoglein 3 augments desmoglein 3 and p38 MAPK phosphorylation in human squamous carcinoma cell line.
Kawasaki Y; Aoyama Y; Tsunoda K; Amagai M; Kitajima Y
Autoimmunity; 2006 Nov; 39(7):587-90. PubMed ID: 17101502
[TBL] [Abstract][Full Text] [Related]
2. No activation of urokinase plasminogen activator by anti-desmoglein 3 monoclonal IgG antibodies in cultured human keratinocytes.
Yamamoto Y; Aoyama Y; Shu E; Tsunoda K; Amagai M; Kitajima Y
J Dermatol Sci; 2007 Aug; 47(2):119-25. PubMed ID: 17532189
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.
Shu E; Yamamoto Y; Aoyama Y; Kitajima Y
Arch Dermatol Res; 2007 Jun; 299(3):165-7. PubMed ID: 17431647
[TBL] [Abstract][Full Text] [Related]
4. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
Cirillo N; Femiano F; Gombos F; Lanza A
Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic human monoclonal antibody against desmoglein 3.
Yeh SW; Cavacini LA; Bhol KC; Lin MS; Kumar M; Duval M; Posner MR; Ahmed AR
Clin Immunol; 2006 Jul; 120(1):68-75. PubMed ID: 16635589
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis--possible involvement of the EGF receptor.
Frusić-Zlotkin M; Raichenberg D; Wang X; David M; Michel B; Milner Y
Autoimmunity; 2006 Nov; 39(7):563-75. PubMed ID: 17101500
[TBL] [Abstract][Full Text] [Related]
7. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes.
Cirillo N; Femiano F; Gombos F; Lanza A
FEBS Lett; 2006 May; 580(13):3276-81. PubMed ID: 16698018
[TBL] [Abstract][Full Text] [Related]
8. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
[TBL] [Abstract][Full Text] [Related]
9. Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells.
Aoyama Y; Kitajima Y
J Invest Dermatol; 1999 Jan; 112(1):67-71. PubMed ID: 9886266
[TBL] [Abstract][Full Text] [Related]
10. Anti-desmoglein 3 (Dsg3) monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity.
Yamamoto Y; Aoyama Y; Shu E; Tsunoda K; Amagai M; Kitajima Y
J Biol Chem; 2007 Jun; 282(24):17866-76. PubMed ID: 17428808
[TBL] [Abstract][Full Text] [Related]
11. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
12. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes.
Aoyama Y; Owada MK; Kitajima Y
Eur J Immunol; 1999 Jul; 29(7):2233-40. PubMed ID: 10427986
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
[TBL] [Abstract][Full Text] [Related]
14. Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation.
Saito M; Stahley SN; Caughman CY; Mao X; Tucker DK; Payne AS; Amagai M; Kowalczyk AP
PLoS One; 2012; 7(12):e50696. PubMed ID: 23226536
[TBL] [Abstract][Full Text] [Related]
15. A new ex vivo human oral mucosa model reveals that p38MAPK inhibition is not effective in preventing autoantibody-induced mucosal blistering in pemphigus.
Egu DT; Sigmund AM; Schmidt E; Spindler V; Walter E; Waschke J
Br J Dermatol; 2020 Apr; 182(4):987-994. PubMed ID: 31218663
[TBL] [Abstract][Full Text] [Related]
16. The expression of desmoglein isoforms in cultured human keratinocytes is regulated by calcium, serum, and protein kinase C.
Denning MF; Guy SG; Ellerbroek SM; Norvell SM; Kowalczyk AP; Green KJ
Exp Cell Res; 1998 Feb; 239(1):50-9. PubMed ID: 9511724
[TBL] [Abstract][Full Text] [Related]
17. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice.
Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T
Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541
[TBL] [Abstract][Full Text] [Related]
18. Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgaris.
Koga H; Tsuruta D; Ohyama B; Ishii N; Hamada T; Ohata C; Furumura M; Hashimoto T
Expert Opin Ther Targets; 2013 Mar; 17(3):293-306. PubMed ID: 23294403
[TBL] [Abstract][Full Text] [Related]
19. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
Femiano F
Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
[TBL] [Abstract][Full Text] [Related]
20. Disruption of desmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies.
Mao X; Choi EJ; Payne AS
J Invest Dermatol; 2009 Apr; 129(4):908-18. PubMed ID: 19037235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
